Methods and devices for activating brown adipose tissue using electrical energy

• US 10,080,884 B2
• Filed: 12/29/2014
• Issued: 09/25/2018
• Est. Priority Date: 12/29/2014
• Status: Active Grant

• Current Assignee: Cilag Gmbh International (Johnson & Johnson)
• Original Assignee: Ethicon, LLC (Johnson & Johnson)
• Inventors: Harris, Jason L., Baynham, Tamara C.
• Primary Examiner(s): MAHMOOD, NADIA AHMAD
• Application Number:
  US14/584,066
• Publication Number:
  US 20160184574A1
• Time in Patent Office: 1,366 Days
• Field of Search: 607 2, 607116
• CPC Class Codes: A61N 1/0456 Specially adapted for transcutaneous electrical nerve stimulation [TENS]
• CPC Class Codes: A61N 1/0492 Patch electrodes A61N1/0412, A61N1/0428 take precedence
• CPC Class Codes: A61N 1/0502 Skin piercing electrodes
• CPC Class Codes: A61N 1/0504 Subcutaneous electrodes
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36034 specified by the stimulation parameters
• CPC Class Codes: A61N 1/36146 specified by the stimulation parameters
• CPC Class Codes: A61N 1/36189 using modulation techniques

Abstract

Methods and devices are provided for activating brown adipose tissue (BAT) using electrical energy. In general, the methods and devices can facilitate activation of BAT to increase thermogenesis. The BAT can be activated by applying an electrical signal thereto that can be configured to target sympathetic nerves that can directly innervate the BAT. The electrical signal can be configured to target the sympathetic nerves using fiber diameter selectivity. In other words, the electrical signal can be configured to activate nerve fibers having a first diameter without activating nerve fibers having diameters different than the first diameter. Sympathetic nerves include postganglionic unmyelinated, small diameter fibers, while parasympathetic nerves that can directly innervate BAT include preganglionic myelinated, larger diameter fibers. The electrical signal can be configured to target and activate the postganglionic unmyelinated, small diameter fibers without activating the preganglionic myelinated, larger diameter fibers.

Claims

1. A medical method, comprising:

positioning a device in contact with tissue of a patient proximate to a depot of brown adipose tissue (BAT); and

activating the device to transcutaneously deliver an electrical signal to the patient so as to activate a first nerve type in the BAT without activating a second, different nerve type in the BAT, the first nerve type having a smaller diameter than the second nerve type, and the electrical signal has a peak current that is at least about 50 mA.

2. The method of claim 1, wherein the first nerve type includes sympathetic nerves, and the second nerve type includes parasympathetic nerves.

3. The method of claim 1, wherein the first nerve type includes sympathetic nerves, and the second nerve type includes sensory nerves.

4. The method of claim 1, wherein the electrical signal has a peak current in a range of about 50 mA to 100 mA.

5. The method of claim 1, wherein the electrical signal has a current of at least 10 mA.

6. The method of claim 1, wherein the electrical signal has a pulse width less than about 400 μ

s.

7. The method of claim 1, wherein the electrical signal is continuously delivered to the patient for at least one day.

8. The method of claim 1, wherein positioning the device comprises positioning at least a partial portion of the device external to the patient, the method further comprising:

after the delivering of the electrical signal so as to activate the first nerve type in the BAT, removing the device from being in contact with the tissue of the patient;

repositioning the device in contact with tissue of the patient proximate to a different depot of BAT; and

activating the device to deliver a second electrical signal to the patient so as to activate the first nerve type in the different depot of BAT without activating a second, different nerve type in the different depot of BAT.

9. A medical method, comprising:

positioning a device in contact with tissue of a patient proximate to a depot of brown adipose tissue (BAT); and

activating the device to deliver an electrical signal to the patient so as to activate unmyelinated neurons in the BAT without activating myelinated neurons in the BAT, the electrical signal having a current of at least 10 mA.

10. The method of claim 9, wherein the myelinated neurons have a diameter in a range of about 2 μ

m to 6 μ

m.

11. The method of claim 9, wherein a peak current of the electrical signal is in a range of about 50 mA to 100 mA.

12. The method of claim 9, wherein the electrical signal has a pulse width less than about 400 μ

s.

13. The method of claim 9, wherein positioning the device comprises transcutaneously applying the device to an exterior skin surface of the patient.

14. The method of claim 9, wherein positioning the device comprises subcutaneously positioning a partial portion of the device within the patient.

15. The method of claim 9, wherein positioning the device comprises implanting the device entirely within the patient.

16. The method of claim 9, wherein the device is in continuous direct contact with the tissue of the patient for at least one day with the device continuously delivering the electrical signal to the patient for the at least one day.